{"id":"https://openalex.org/W15808270","doi":null,"title":"Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant.","display_name":"Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant.","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W15808270","mag":"15808270","pmid":"https://pubmed.ncbi.nlm.nih.gov/17127828"},"language":"en","primary_location":{"id":"pmid:17127828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17127828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Le infezioni in medicina","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022287365","display_name":"Gaetano Scotto","orcid":"https://orcid.org/0000-0002-1406-7797","observed_orcids":["https://orcid.org/0000-0002-1406-7797"]},"institutions":[{"id":"https://openalex.org/I106296451","display_name":"University of Foggia","ror":"https://ror.org/01xtv3204","country_code":"IT","type":"education","lineage":["https://openalex.org/I106296451"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gaetano Scotto","raw_affiliation_strings":["Clinic of Infectious Diseases, University of Foggia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of Infectious Diseases, University of Foggia, Italy","institution_ids":["https://openalex.org/I106296451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003109164","display_name":"Emilio Palumbo","orcid":"https://orcid.org/0000-0003-4599-8161","observed_orcids":["https://orcid.org/0000-0003-4599-8161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilio Palumbo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054532823","display_name":"Vincenzina Fazio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincenzina Fazio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066449598","display_name":"Donatella Concetta Cibelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donatella Concetta Cibelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081103796","display_name":"Annalisa Saracino","orcid":"https://orcid.org/0000-0001-9558-208X","observed_orcids":["https://orcid.org/0000-0001-9558-208X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annalisa Saracino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012360574","display_name":"Gioacchino Angarano","orcid":"https://orcid.org/0000-0003-3207-7523","observed_orcids":["https://orcid.org/0000-0003-3207-7523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gioacchino Angarano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4231,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.6567546,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"14","issue":"3","first_page":"145","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-active-hepatitis-b","display_name":"chronic active hepatitis B","score":0.7739999890327454},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/precore-mutant","display_name":"precore mutant","score":0.703000009059906},{"id":"https://openalex.org/keywords/anti-hbe-positive","display_name":"anti-HBe positive","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9129999876022339},{"id":"https://openalex.org/keywords/antiviral-efficacy","display_name":"antiviral efficacy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.6650000214576721},{"id":"https://openalex.org/keywords/nucleos-t-ide-analogues","display_name":"nucleos(t)ide analogues","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.9927747249603271},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9137203693389893},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7749125361442566},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.624139130115509},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.6110538244247437},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.579669713973999},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.563671886920929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5419467687606812},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.4949032664299011},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.48714134097099304},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.45738548040390015},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34732696413993835},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.34439826011657715},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30125683546066284},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.12664121389389038}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:17127828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17127828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Le infezioni in medicina","raw_type":"Comparative Study"},{"id":"pmh:oai:ricerca.uniba.it:11586/123823","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11586/123823","pdf_url":null,"source":{"id":"https://openalex.org/S4377196296","display_name":"CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5561750","host_organization_name":"University of Bari Aldo Moro","host_organization_lineage":["https://openalex.org/I5561750"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1515724078","https://openalex.org/W2379873882","https://openalex.org/W2350018785","https://openalex.org/W7108517990","https://openalex.org/W1994449949","https://openalex.org/W2357312806","https://openalex.org/W2358507749","https://openalex.org/W2410416037","https://openalex.org/W2149337924","https://openalex.org/W2187341310"],"abstract_inverted_index":{"The":[0,88],"aim":[1],"of":[2,12,21,116],"our":[3],"study":[4,104],"was":[5,96],"to":[6],"assess":[7],"the":[8,74,93,129,145],"efficacy":[9],"and":[10],"tolerability":[11],"lamivudine":[13,16,42,54,84,117,126,138],"alone":[14],"versus":[15],"plus":[17,58,118],"alpha-interferon":[18,59],"for":[19,47,67,78,85,132,139],"treatment":[20],"chronic":[22,110],"active":[23],"hepatitis":[24,111],"B,":[25],"anti-HBe":[26,108],"positive.":[27],"In":[28],"all,":[29],"59":[30],"patients":[31,40,52,72],"were":[32],"randomly":[33],"divided":[34],"into":[35],"3":[36],"groups:":[37],"A)":[38],"21":[39],"received":[41,53,73],"at":[43,55,60],"100":[44,56],"mg/daily":[45],"orally":[46],"52":[48,68],"weeks;":[49,69],"B)":[50],"20":[51],"mg/die":[57],"6":[61],"MU":[62],"subcutaneously":[63],"three":[64,94],"times":[65],"weekly":[66],"C)":[70],"18":[71],"same":[75],"combination":[76,120,130],"therapy":[77,121,131],"40":[79,133],"weeks":[80,134,141],"after":[81,135],"pre-treatment":[82,136],"with":[83,137],"12":[86,140],"weeks.":[87],"complete":[89],"sustained":[90,146],"response":[91],"in":[92,107],"groups":[95],"33.3%":[97],"vs":[98,100],"35.0%":[99],"33.3%,":[101],"respectively.":[102],"Our":[103],"demonstrates":[105],"that":[106],"positive":[109],"B":[112],"a":[113],"12-month":[114],"course":[115],"a-interferon":[119],"is":[122],"as":[123,125],"beneficial":[124],"monotherapy.":[127],"Moreover,":[128],"did":[142],"not":[143],"increase":[144],"response.":[147]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}